Samir Rashmikant Patel
CIK: 0001702447
Associated companies
Transaction History
| AKTX | ▲ Buy | Option Exercise | 1,209 | $10K | 7/7/2026 | View on chart |
| AKTX | ▲ Buy | Option Exercise | 15,466 | $6 | 7/7/2026 | View on chart |
| AKTX | ▲ Buy | Option Exercise | 5,799 | $2 | 7/7/2026 | View on chart |
| AKTX | ▲ Buy | Grant | 406,250 | $455K | 3/6/2025 | View on chart |
| AKTX | ▲ Buy | Grant | 208,000 | $125 | 1/3/2025 | View on chart |
| AKTX | ▲ Buy | Grant | 400,000 | $200 | 12/27/2024 | View on chart |
| AKTX | ▲ Buy | Grant | 3,200,000 | $2K | 12/26/2024 | View on chart |
| AKTX | ▲ Buy | Grant | 7,500,000 | $4K | 12/24/2024 | View on chart |
| AKTX | ▲ Buy | Grant | 1,400,000 | $700 | 12/23/2024 | View on chart |
| AKTX | ▲ Buy | Grant | 1,400,000 | $700 | 12/20/2024 | View on chart |
| AKTX | ▲ Buy | Grant | 419,286,000 | $503K | 12/2/2024 | View on chart |
| AKTX | ▲ Buy | Grant | 1,404,622,000 | — | 11/14/2024 | View on chart |
| AKTX | ▲ Buy | Grant | 91,396,000 | $0 | 6/30/2024 | View on chart |
| AKTX | ▲ Buy | Grant | 1,326,258,000 | $1.2M | 5/31/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
Akari Therapeutics Files New Patent Application
Akari Therapeutics has submitted a new patent application to expand its intellectual property portfolio. This move is relevant as it aims to strengthen the company's long-term position in its therapeutic areas. The stock currently trades well below its 52-week high, reflecting the significant volatility seen in the sector.
Akari Therapeutics Files New Patent Application. Akari Therapeutics has submitted a new patent application to expand its intellectual property portfolio. This move is relevant as it aims to strengthen the company's long-term position in its therapeutic areas. The stock currently trades well below its 52-week high, reflecting the significant volatility seen in the sector.